BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21757341)

  • 1. Recognition of HIV TAR RNA by triazole linked neomycin dimers.
    Kumar S; Arya DP
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4788-92. PubMed ID: 21757341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Click dimers to target HIV TAR RNA conformation.
    Kumar S; Kellish P; Robinson WE; Wang D; Appella DH; Arya DP
    Biochemistry; 2012 Mar; 51(11):2331-47. PubMed ID: 22339203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivalency in the recognition and antagonism of a HIV TAR RNA-TAT assembly using an aminoglycoside benzimidazole scaffold.
    Kumar S; Ranjan N; Kellish P; Gong C; Watkins D; Arya DP
    Org Biomol Chem; 2016 Feb; 14(6):2052-6. PubMed ID: 26765486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multivalent Amino Sugars to Recognize Different TAR RNA Conformations.
    Kellish PC; Kumar S; Mack TS; Spano MN; Hennig M; Arya DP
    Medchemcomm; 2014 Aug; 5(8):1235-1246. PubMed ID: 27076899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of HIV-TAR RNA using neomycin-benzimidazole conjugates.
    Ranjan N; Kumar S; Watkins D; Wang D; Appella DH; Arya DP
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5689-93. PubMed ID: 24012122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of neomycin to the TAR element of HIV-1 RNA induces dissociation of Tat protein by an allosteric mechanism.
    Wang S; Huber PW; Cui M; Czarnik AW; Mei HY
    Biochemistry; 1998 Apr; 37(16):5549-57. PubMed ID: 9548939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Small Molecules with a Noncanonical Binding Mode to HIV-1 Trans Activation Response (TAR) RNA.
    Abulwerdi FA; Shortridge MD; Sztuba-Solinska J; Wilson R; Le Grice SF; Varani G; Schneekloth JS
    J Med Chem; 2016 Dec; 59(24):11148-11160. PubMed ID: 28002966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neamine dimers targeting the HIV-1 TAR RNA.
    Riguet E; Désiré J; Boden O; Ludwig V; Göbel M; Bailly C; Décout JL
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4651-5. PubMed ID: 16153833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Synthesis, and Evaluation of Neomycin-Imidazole Conjugates for RNA Cleavage.
    Martin C; Bonnet M; Patino N; Azoulay S; Di Giorgio A; Duca M
    Chempluschem; 2022 Nov; 87(11):e202200250. PubMed ID: 36148854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural rearrangements of HIV-1 Tat-responsive RNA upon binding of neomycin B.
    Faber C; Sticht H; Schweimer K; Rösch P
    J Biol Chem; 2000 Jul; 275(27):20660-6. PubMed ID: 10747964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visualizing a specific contact in the HIV-1 Tat protein fragment and trans-activation responsive region RNA complex by photocross-linking.
    Liu Y; Wang Z; Rana TM
    J Biol Chem; 1996 Apr; 271(17):10391-6. PubMed ID: 8626612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neomycin-neomycin dimer: an all-carbohydrate scaffold with high affinity for AT-rich DNA duplexes.
    Kumar S; Xue L; Arya DP
    J Am Chem Soc; 2011 May; 133(19):7361-75. PubMed ID: 21524066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermodynamic studies of a series of homologous HIV-1 TAR RNA ligands reveal that loose binders are stronger Tat competitors than tight ones.
    Pascale L; Azoulay S; Di Giorgio A; Zenacker L; Gaysinski M; Clayette P; Patino N
    Nucleic Acids Res; 2013 Jun; 41(11):5851-63. PubMed ID: 23605042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-induced changes in 2-aminopurine fluorescence as a probe for small molecule binding to HIV-1 TAR RNA.
    Bradrick TD; Marino JP
    RNA; 2004 Sep; 10(9):1459-68. PubMed ID: 15273324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding affinity and inhibitory potency of neomycin and streptomycin on the Tat peptide interaction with HIV-1 TAR RNA detected by on-line acoustic wave sensor.
    Tassew N; Thompson M
    Org Biomol Chem; 2003 Oct; 1(19):3268-70. PubMed ID: 14584788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element.
    Vickers T; Baker BF; Cook PD; Zounes M; Buckheit RW; Germany J; Ecker DJ
    Nucleic Acids Res; 1991 Jun; 19(12):3359-68. PubMed ID: 2062653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling of HIV-1 TAR RNA-ligand complexes.
    Mitrasinovic PM; Tomar JS; Nair MS; Barthwal R
    Med Chem; 2011 Jul; 7(4):301-8. PubMed ID: 21574948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic ensemble view of the conformational landscape of HIV-1 TAR RNA and allosteric recognition.
    Lu J; Kadakkuzha BM; Zhao L; Fan M; Qi X; Xia T
    Biochemistry; 2011 Jun; 50(22):5042-57. PubMed ID: 21553929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of TAR RNA complexed with a Tat-TAR interaction nanomolar inhibitor that was identified by computational screening.
    Du Z; Lind KE; James TL
    Chem Biol; 2002 Jun; 9(6):707-12. PubMed ID: 12079782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antiviral activity of ethidium-arginine conjugates directed against the TAR RNA of HIV-1.
    Peytou V; Condom R; Patino N; Guedj R; Aubertin AM; Gelus N; Bailly C; Terreux R; Cabrol-Bass D
    J Med Chem; 1999 Oct; 42(20):4042-53. PubMed ID: 10514274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.